Educating People with Epilepsy and Their Families

Introduction 65 million people worldwide suffer from epilepsy and growing health problems. At one point in their lives, one in two in the United States is diagnosed epilepsy. Epilepsy affects people of all ages and backgrounds (TEF, 2013). 60% of cases are unknown. Stroke affects various parts of the brain and is caused by various factors including genetic, symptomatic, or idiopathic. Convulsions can manifest itself as part (including one side of the brain) or systemic (including both sides of the brain) and absence (people stare into the blank for a few seconds), disorders (people who consciously fall to the ground) Yes.

People with epilepsy may feel frightened by themselves, their families, and members of other communities. Epilepsy can be caused by inflicted head trauma or by maternal infections such as meningitis and syphilis. Epilepsy is not an infectious disease and there is no danger of getting it from other people. Epilepsy can be treated and managed with appropriate medicine and when epileptic patients take medicine they can play an adequate role in the community.

We are directly aware of the medical complexity of epilepsy and the difficult decisions encountered by epilepsy patients and their families. We all consult with epilepsy experts to make decisions based on adequate information with experts so that all people with epilepsy can compare the risks and benefits of various treatment options We will explore existing treatment options.

Each epilepsy case is different, the disease itself is very variable. Certain treatments effective for certain types of epilepsy are ineffective or even worse for other types of epilepsy. Scientific research on people with epilepsy helps to understand how and why different treatments work and who they work for. The survey also helps us understand the correct doses, side effects and potential interactions with other medications. In this study it was necessary to judge whether a cannabis derivative has been safely and effectively treated in epilepsy children or adults and did not happen without funds. Currently, it is difficult if not impossible to obtain Federal funds to complete a medical cannabis study because cannabis is designated as a DEA plan 1 medicine.